STX-301

N/A

Report date: 2025/01/26 17:17:06

Base Information

Drug NameSTX-301
Drug Alias NameSTX-301
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynthex Labs
China Registration ClassN/A

Develop Information

Active CompaniesSynthex Labs
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A